全文获取类型
收费全文 | 9445篇 |
免费 | 750篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 354篇 |
妇产科学 | 304篇 |
基础医学 | 1207篇 |
口腔科学 | 292篇 |
临床医学 | 867篇 |
内科学 | 1886篇 |
皮肤病学 | 107篇 |
神经病学 | 544篇 |
特种医学 | 341篇 |
外科学 | 1549篇 |
综合类 | 446篇 |
一般理论 | 10篇 |
预防医学 | 444篇 |
眼科学 | 341篇 |
药学 | 482篇 |
1篇 | |
中国医学 | 31篇 |
肿瘤学 | 984篇 |
出版年
2023年 | 58篇 |
2022年 | 78篇 |
2021年 | 223篇 |
2020年 | 151篇 |
2019年 | 193篇 |
2018年 | 256篇 |
2017年 | 136篇 |
2016年 | 193篇 |
2015年 | 265篇 |
2014年 | 353篇 |
2013年 | 371篇 |
2012年 | 564篇 |
2011年 | 643篇 |
2010年 | 443篇 |
2009年 | 404篇 |
2008年 | 588篇 |
2007年 | 633篇 |
2006年 | 605篇 |
2005年 | 533篇 |
2004年 | 499篇 |
2003年 | 425篇 |
2002年 | 336篇 |
2001年 | 327篇 |
2000年 | 274篇 |
1999年 | 226篇 |
1998年 | 96篇 |
1997年 | 97篇 |
1996年 | 82篇 |
1995年 | 58篇 |
1994年 | 70篇 |
1993年 | 49篇 |
1992年 | 118篇 |
1991年 | 99篇 |
1990年 | 100篇 |
1989年 | 100篇 |
1988年 | 73篇 |
1987年 | 74篇 |
1986年 | 68篇 |
1985年 | 60篇 |
1984年 | 44篇 |
1983年 | 39篇 |
1982年 | 33篇 |
1981年 | 34篇 |
1980年 | 25篇 |
1979年 | 24篇 |
1978年 | 22篇 |
1977年 | 26篇 |
1976年 | 19篇 |
1975年 | 13篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Distribution of type I, II, III and V in the pepsin solubilized collagens in bovine menisci 总被引:3,自引:0,他引:3
H S Cheung 《Connective tissue research》1987,16(4):343-356
The inner one-third (IM) of both lateral and medial menisci resembles hyaline cartilage, both in gross appearance and histological examination, while the outer two-thirds (OM) is fibrocartilaginous in appearance. Collagen was extracted with pepsin, purified with anion and cation exchange column chromatographies and examined by differential salt precipitation, cyanogen bromide-peptide analysis and SDS gel electrophoresis. IM constitutes approximately 10% of the wet weight of whole meniscus, is made up of 70% collagen of which 34% is pepsin soluble. IM is composed of 60% type II and 40% type I collagen. OM is made up of 80% collagen of which 17% is pepsin soluble. The predominant collagen of OM is type I with a trace amount of types III and V (less than 1%). 相似文献
92.
De Boer RH Roskos LK Cheung E Fox S Basser RL Marty J Begley CG Cebon J 《Growth factors (Chur, Switzerland)》2000,18(3):215-226
Phase I studies with pegylated megakaryocyte growth and development factor (PEG-rHuMGDF), a c-Mpl ligand that stimulates megakaryopoiesis, have demonstrated that PEG-rHuMGDF is biologically active alone and causes a dose-related enhancement of platelet recovery when administered after chemotherapy. Here we report the dose-ranging pharmacokinetics of PEG-rHuMGDF. Pre-injection blood samples were drawn daily for pharmacokinetic studies on 43 patients. An ELISA, established using PEG-rHuMGDF as the standard, was able to quantitate Mpl ligand at concentrations > 0.02 ng/mL. Over the dose range 0.03 to 5.0 microg/kg/day, subcutaneous administration produced linear increases in steady-state serum levels. Maximum levels of PEG-rHuMGDF attained after 5.0 microg/kg/day were 5.88 to 10.9 ng/mL. After discontinuation of PEG-rHuMGDF, concentrations of Mpl ligand returned to baseline within 5 days. The pharmacokinetics were best described by a one-compartment model with first-order absorption, an absorption delay, and non linear clearance over the first 48 hours. The mean terminal half-life was 33.3 + 16.7 hours, and the average apparent at steady state was 27.7 + 14.0 mL/h/kg; both were independent of administered dose. The apparent clearance of PEG-rHuMGDF was not predicted by platelet count. Administration of chemotherapy and Filgrastim did not alter the pharmacokinetics of PEG-rHuMGDF. 相似文献
93.
Sau W Cheung Chad A Shaw Wei Yu Jiangzham Li Zhishuo Ou Ankita Patel Svetlana A Yatsenko Mitchell L Cooper Patti Furman Pawel Stankiewicz Pawal Stankiewicz James R Lupski A Craig Chinault Arthur L Beaudet 《Genetics in medicine》2005,7(6):422-432
PURPOSE: We developed a microarray for clinical diagnosis of chromosomal disorders using large insert genomic DNA clones as targets for comparative genomic hybridization (CGH). METHODS: The array contains 362 FISH-verified clones that span genomic regions implicated in over 40 known human genomic disorders and representative subtelomeric clones for each of the 41 clinically relevant human chromosome telomeres. Three or four clones from almost all deletion or duplication genomic regions and three or more clones for each subtelomeric region were included. We tested chromosome microarray analysis (CMA) in a masked fashion by examining genomic DNA from 25 patients who were previously ascertained in a genetic clinic and studied by conventional cytogenetics. A novel software package implemented in the R statistical programming language was developed for normalization, visualization, and inference. RESULTS: The CMA results were entirely consistent with previous cytogenetic and FISH findings. For clone by clone analysis, the sensitivity was estimated to be 96.7% and the specificity was 99.1%. Major advantages of this selected human genome array include the following: interrogation of clinically relevant genomic regions, the ability to test for a wide range of duplication and deletion syndromes in a single analysis, the ability to detect duplications that would likely be undetected by metaphase FISH, and ease of confirmation of suspected genomic changes by conventional FISH testing currently available in the cytogenetics laboratory. CONCLUSION: The array is an attractive alternative to telomere FISH and locus-specific FISH, but it does not include uniform coverage across the arms of each chromosome and is not intended to substitute for a standard karyotype. Limitations of CMA include the inability to detect both balanced chromosome changes and low levels of mosaicism. 相似文献
94.
95.
The peroxisome proliferator-activated receptor- (PPAR), first identified in 1990 as a member of the nuclear receptor superfamily, has a central role in the regulation of numerous target genes encoding proteins that modulate fatty acid transport and catabolism. PPAR is the molecular target for the widely prescribed lipid-lowering fibrate drugs and the diverse class of chemicals collectively referred to as peroxisome proliferators. The lipid-lowering function of PPAR occurs across a number of mammalian species, thus demonstrating the essential role of this nuclear receptor in lipid homeostasis. In contrast, prolonged administration of PPAR agonists causes hepatocarcinogenesis, specifically in rats and mice, indicating that PPAR also mediates this effect. There is no strong evidence that the low-affinity fibrate ligands are associated with cancer in humans, but it still remains a possibility that chronic activation with high-affinity ligands could be carcinogenic in humans. It is now established that the species difference between rodents and humans in response to peroxisome proliferators is due in part to PPAR. The cascade of molecular events leading to liver cancer in rodents involves hepatocyte proliferation and oxidative stress, but the PPAR target genes that mediate this response are unknown. This review focuses on the current understanding of the role of PPAR in hepatocarcinogenesis and identifies future research directions that should be taken to delineate the mechanisms underlying PPAR agonist-induced hepatocarcinogenesis. 相似文献
96.
Cheung NT Fung KW Wong KC Cheung A Cheung J Ho W Cheung C Shung E Fung V Fung H 《International journal of medical informatics》2001,62(2-3):113-119
Since its inception in 1990, the Hospital Authority (HA) has strongly supported the development and implementation of information systems both to improve the delivery of care and to make better information available to managers. This paper summarizes the progress to date and discusses current and future developments. Following the first two phases of the HA information technology strategy the basic infrastructural elements were laid in place. These included the foundation administrative and financial systems and databases; establishment of a wide area network linking all hospitals and clinics together; laboratory, radiology and pharmacy systems with access to results in the ward. A major push into clinical systems began in 1994 with the clinical management system (CMS), which established a clinical workstation for use in both ward and ambulatory settings. The CMS is now running at all major hospitals, and provides single logon access to almost all the electronically collected clinical data in the HA. The next phase of development is focussed on further support for clinical activities in the CMS. Key elements include the longitudinal electronic patient record (ePR), clinical order entry, generic support for clinical reports, broadening the scope to include allied health and the rehabilitative phase, clinical decision support, an improved clinical documentation framework, sharing of clinical information with other health care providers and a comprehensive data repository for analysis and reporting purposes. 相似文献
97.
Complete nucleotide sequence of the 27-kilobase virulence related locus (vrl) of Dichelobacter nodosus: evidence for extrachromosomal origin 下载免费PDF全文
Billington SJ Huggins AS Johanesen PA Crellin PK Cheung JK Katz ME Wright CL Haring V Rood JI 《Infection and immunity》1999,67(3):1277-1286
The vrl locus is preferentially associated with virulent isolates of the ovine footrot pathogen, Dichelobacter nodosus. The complete nucleotide sequence of this 27.1-kb region has now been determined. The data reveal that the locus has a G+C content much higher than the rest of the D. nodosus chromosome and contains 22 open reading frames (ORFs) encoding products including a putative adenine-specific methylase, two potential DEAH ATP-dependent helicases, and two products with sequence similarity to a bacteriophage resistance system. These ORFs are all in the same orientation, and most are either overlapping or separated by only a few nucleotides, suggesting that they comprise an operon and are translationally coupled. Expression vector studies have led to the identification of proteins that correspond to many of these ORFs. These data, in combination with evidence of insertion of vrl into the 3' end of an ssrA gene, are consistent with the hypothesis that the vrl locus was derived from the insertion of a bacteriophage or plasmid into the D. nodosus genome. 相似文献
98.
99.
100.